ContraFect Corporation ContraFect Corporation Nasdaq: CFRX

Navigate ContraFect Corporation

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Lysins
    • Amurins
    • Publications / Posters
    • Video Library
  • Pipeline
    • Overview
    • Exebacase
    • CF-370
    • Gram-negative Lysins
    • Amurins
  • Investors & Media
    • Overview
    • News / Events
    • Presentations
    • Company Information
    • Financial Information
    • Analyst Coverage
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Careers
  • Contact Us

Board of Directors

Investors & Media

  • Home
  • Investors & Media
  • Corporate Governance
  • Board of Directors
Investors & Media

Investors & Media

  • Overview
  • News / Events
  • Presentations
  • Company Information
  • Financial Information
  • Analyst Coverage
  • Stock Data
  • SEC Filings
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
Roger J. Pomerantz, M.D., F.A.C.P. President, Chief Executive Officer and Chairman of the Board Roger J. Pomerantz, M.D., F.A.C.P. View Bio
Sol J. Barer, Ph.D. Lead Independent Director Sol J. Barer, Ph.D. View Bio
Steven C. Gilman, Ph.D. Vice Chairman of the Board Steven C. Gilman, Ph.D. View Bio
Cary W. Sucoff, J.D. Director Cary W. Sucoff, J.D. View Bio
David N. Low, Jr. Director David N. Low, Jr. View Bio
Michael J. Otto, Ph.D. Director Michael J. Otto, Ph.D. View Bio
Lishan Aklog, M.D. Director Lishan Aklog, M.D. View Bio
Jane F. Barlow, MD, MPH, MBA Director Jane F. Barlow, MD, MPH, MBA View Bio

Observers

Annaliesa Anderson, PhD, FAAM Science & Technology Committee Observer Annaliesa Anderson, PhD, FAAM View Bio
© 2023 ContraFect Corporation. All Rights Reserved.
Copyright Privacy Policy Expanded Access Policy Disclaimer Site Map
LinkedIn Twitter